We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
International reports indicate that Germany's innovative pharmaceuticals
sector continues to suffer amid the government's cost-conscious healthcare reforms.
Sources within Japan's research-based pharmaceuticals sector have highlighted
that the country's clinical trials market appears to be in decline, faced with
growing regional competition.
UK drugmaker ProStrakan said it had raised 40 million pounds ($73 million) in
a placing at 100 pence per share, valuing the company at around 180 million
pounds, down sharply from the valuation it had hoped to achieve a month ago.
Clemex Technologies announces that its Board of Directors approved the redemption
of half of the $500,000 debentures held by 3880095 Canada (Raffaele Gerbasi),
at its Board meeting.
Two San Diego-based specialty pharmaceutical firms, Verus Pharmaceuticals Inc.
and Somaxon Pharmaceuticals Inc., announced they raised $163 million total in
venture capital funding.
InfaCare Pharmaceutical Corporation and Recordati, a pharmaceutical company
based in Milan, Italy, jointly announced the signing of an exclusive licensing
agreement that provides Recordati the rights to develop and market Stanate (stannsoporfin),
a first-in-class agent for the treatment of jaundice in babies, for Europe and
for certain territories of Northern Africa and the Middle East.
Germany's Schering AG (SHR)
Monday opened its Asia-Pacific headquarters in Singapore, joining a number of
drug companies that have decided to locate their regional management activities
in the city-state.
Israel is likely to ignore US opposition to two key new intellectual
property measures: the data exclusivity bill approved in March and a draft amendment
to the country's Patent Law.
Influential media sources have urged Brazil's president, Luiz Inacio 'Lula'
da Silva, to veto a law that envisages breaking patents held by US drugmakers
on HIV/AIDS therapies.